DUNHAM APPRECIATION & INCOME FUND DUNHAM APPRECIATION & INCOME FUND CLASS A (DAAIX US) stock market data APIs
8.6778
0(0%)
as of May 15, 2025
Try our APIs with
free plan!
DUNHAM APPRECIATION & INCOME FUND DUNHAM APPRECIATION & INCOME FUND CLASS A Financial Data Overview
Prev. Close
8.6778
Open
8.6778
High
8.6778
Low
8.6778
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get DUNHAM APPRECIATION & INCOME FUND DUNHAM APPRECIATION & INCOME FUND CLASS A data using free add-ons & libraries
End-of-day & Earnings data
Get DUNHAM APPRECIATION & INCOME FUND DUNHAM APPRECIATION & INCOME FUND CLASS A Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get DUNHAM APPRECIATION & INCOME FUND DUNHAM APPRECIATION & INCOME FUND CLASS A End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
DUNHAM APPRECIATION & INCOME FUND DUNHAM APPRECIATION & INCOME FUND CLASS A News
New
AACSB Announces 2021 Class of Influential Leaders
Sixth annual Influential Leaders initiative recognizes 25 outstanding business school graduates for contributions to society TAMPA, Fla., Feb. 16, 2021 /CNW/ -- AACSB International (AACSB)—the worl...
AACSB Announces 2021 Class of Influential Leaders
Sixth annual Influential Leaders initiative recognizes 25 outstanding business school graduates for contributions to society TAMPA, Fla., Feb. 16, 2021 /CNW/ -- AACSB International (AACSB)—the worl...
Grifols' anti-SARS-CoV-2 hyperimmune globulin begins clinical trial in patients with COVID-19
-- The trial, part of a collaboration with U.S. government agencies including BARDA, the FDA and the NIH, will evaluate the safety, efficacy and tolerability of the anti-SARS-CoV-2 hyperimmune globuli...
Is Grifols SA (GRFS) Going to Burn These Hedge Funds?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that sm...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
